Patent · US Active

Chimeric receptors and methods of use thereof

US10597456B2 · kind B2 · utility

2Cited by
21References
46Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 31, 2017
Grant dateMar 24, 2020
Priority date
Expiry dateMar 31, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/15043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.